EUVIMEDEUVIMED entdecken
Crossref

Development and Optimization of Rutin-Loaded Intranasal Nanoemulsion for Enhanced Nasal Permeation and Drug Release

Preetha Puthezhath, C. K. Dhanapal, B. Dinesh Kumar

International Journal of Drug Delivery Technology · 05.06.2026 · 16 (49s)

DOI: 10.25258/ijddt.16.49s.56 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 05.06.2026. Verfasst von Preetha Puthezhath und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The effective treatment of central nervous system (CNS) disorders remains a major challenge due to the restrictive nature of the blood–brain barrier (BBB), which limits the delivery of therapeutic agents to the brain. Intranasal drug delivery has emerged as a promising non-invasive approach for direct nose-to-brain transport, bypassing the BBB and improving brain bioavailability. The present study aimed to develop and optimize a rutin-loaded intranasal nanoemulsion for enhanced nasal permeation and drug release using a low-pressure homogenization technique. Rutin, a naturally occurring flavonoid with potent antioxidant and neuroprotective properties, suffers from poor aqueous solubility and low oral bioavailability, thereby limiting its therapeutic application in neurological disorders. Nanoemulsions were formulated using oleic acid as the oil phase, Cremophor EL as surfactant, and polyethylene glycol 400 as co-surfactant. Pseudo ternary phase diagrams were constructed to identify the nanoemulsion region, and formulations were optimized based on droplet size, zeta potential, and drug release characteristics. The optimized formulation exhibited a droplet size of approximately 76 nm with narrow size distribution and satisfactory zeta potential, indicating good physical stability. In vitro drug release studies demonstrated sustained and enhanced release of rutin from the nanoemulsion compared to conventional formulations. Ex vivo nasal permeation studies further revealed improved permeation across nasal mucosa, suggesting enhanced nose-to-brain delivery potential. The developed nanoemulsion showed acceptable physicochemical characteristics, stability, isotonicity, and compatibility for intranasal administration. The findings suggest that intranasal nanoemulsion-based delivery of rutin may represent a promising strategy for improving brain targeting and therapeutic efficacy of neuroprotective agents. Furthermore, the study highlights the potential of low-pressure homogenization as a simple, cost-effective, and scalable approach for the development of intranasal nanoemulsion systems for CNS drug delivery.

Zitieren

APA

Puthezhath, P., Dhanapal, C. K., & Kumar, B. D. (2026). Development and Optimization of Rutin-Loaded Intranasal Nanoemulsion for Enhanced Nasal Permeation and Drug Release. International Journal of Drug Delivery Technology, 16(49s). https://doi.org/10.25258/ijddt.16.49s.56

Vancouver

Puthezhath P, Dhanapal CK, Kumar BD. Development and Optimization of Rutin-Loaded Intranasal Nanoemulsion for Enhanced Nasal Permeation and Drug Release. International Journal of Drug Delivery Technology. 2026;16(49s). doi:10.25258/ijddt.16.49s.56

BibTeX
@article{Puthezhath2026,
  author = {Puthezhath, Preetha and Dhanapal, C. K. and Kumar, B. Dinesh},
  title = {Development and Optimization of Rutin-Loaded Intranasal Nanoemulsion for Enhanced Nasal Permeation and Drug Release},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {49s},
  doi = {10.25258/ijddt.16.49s.56}
}
Kostenlos starten →